Comments on: Massachusetts Business Czar Greg Bialecki’s Innovation Agenda: The Xconomy Interview, Part Two http://www.xconomy.com/boston/2009/09/04/massachusetts-business-czar-greg-bialeckis-innovation-agenda-the-xconomy-interview-part-two/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Yannick Pouliot http://www.xconomy.com/boston/2009/09/04/massachusetts-business-czar-greg-bialeckis-innovation-agenda-the-xconomy-interview-part-two/comment-page-1/#comment-79998 Yannick Pouliot Sun, 06 Sep 2009 06:47:53 +0000 http://www.xconomy.com/?p=40102#comment-79998 Great interview. I found Mr. Bialecki’s comment about "what great ideas are behind the university walls right now that aren’t coming out?" stirring, as this is precisely the motivation for ResearchScorecard.com's expertise finding database, available free at ResearchScorecard.com. This (relatively new) class of knowledge management systems makes it possible for parties external to universities to peer behind their walls and discover the kinds of biomedical research ongoing, and to do so in *quantitative terms*. Furthermore, one of ResearchScorecard's specific goals is to enable investors to quickly identify laboratories that are operating in their field of interest and how well they are doing. I wouldn't claim that we've solved the Ivory Tower problem just yet, but our system and others of its ilk (e.g., Collexis) are the beginnings of a technology that can greatly in increase the transparency needed for technologists and investors to come together in the most informed manner possible. Great interview. I found Mr. Bialecki’s comment about “what great ideas are behind the university walls right now that aren’t coming out?” stirring, as this is precisely the motivation for ResearchScorecard.com’s expertise finding database, available free at ResearchScorecard.com.

This (relatively new) class of knowledge management systems makes it possible for parties external to universities to peer behind their walls and discover the kinds of biomedical research ongoing, and to do so in *quantitative terms*.

Furthermore, one of ResearchScorecard’s specific goals is to enable investors to quickly identify laboratories that are operating in their field of interest and how well they are doing.

I wouldn’t claim that we’ve solved the Ivory Tower problem just yet, but our system and others of its ilk (e.g., Collexis) are the beginnings of a technology that can greatly in increase the transparency needed for technologists and investors to come together in the most informed manner possible.

]]>